Your browser doesn't support javascript.
loading
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity.
Wallberg, Maja; Recino, Asha; Phillips, Jenny; Howie, Duncan; Vienne, Margaux; Paluch, Christopher; Azuma, Miyuki; Wong, F Susan; Waldmann, Herman; Cooke, Anne.
Afiliação
  • Wallberg M; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Recino A; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Phillips J; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Howie D; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Vienne M; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Paluch C; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Azuma M; Department of Molecular Immunology Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
  • Wong FS; Diabetes Research Group, Institute of Molecular and Experimental Medicine, Cardiff School of Medicine, Cardiff University, Cardiff, UK.
  • Waldmann H; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Cooke A; Department of Pathology, University of Cambridge, Cambridge, UK.
Immunology ; 151(2): 248-260, 2017 06.
Article em En | MEDLINE | ID: mdl-28211040

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Regulação para Cima / Complexo CD3 / Receptor de Morte Celular Programada 1 / Inflamação / Anticorpos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Regulação para Cima / Complexo CD3 / Receptor de Morte Celular Programada 1 / Inflamação / Anticorpos Idioma: En Ano de publicação: 2017 Tipo de documento: Article